These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3496893)

  • 1. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study.
    Simons LA; Dwyer T; Simons J; Bernstein L; Mock P; Poonia NS; Balasubramaniam S; Baron D; Branson J; Morgan J
    Atherosclerosis; 1987 May; 65(1-2):181-9. PubMed ID: 3496893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
    Nestel P; Billington T
    Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
    Smith D; Watts GF; Dane-Stewart C; Mamo JC
    Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperlipidemia and remnant lipoproteins.
    Havel RJ
    Curr Opin Lipidol; 1994 Apr; 5(2):102-9. PubMed ID: 8044412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.
    Boquist S; Ruotolo G; Tang R; Björkegren J; Bond MG; de Faire U; Karpe F; Hamsten A
    Circulation; 1999 Aug; 100(7):723-8. PubMed ID: 10449694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
    Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
    Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia.
    Boquist S; Karpe F; Danell-Toverud K; Hamsten A
    Atherosclerosis; 2002 May; 162(1):163-70. PubMed ID: 11947910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
    Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
    J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial lipoproteins and progression of coronary atherosclerosis.
    Karpe F; Steiner G; Uffelman K; Olivecrona T; Hamsten A
    Atherosclerosis; 1994 Mar; 106(1):83-97. PubMed ID: 8018110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.
    Steiner G; Schwartz L; Shumak S; Poapst M
    Circulation; 1987 Jan; 75(1):124-30. PubMed ID: 3791598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease.
    Marcovina S; Zoppo A; Graziani MS; Vassanelli C; Catapano AL
    Ric Clin Lab; 1988; 18(4):319-28. PubMed ID: 3150125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
    Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
    J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.
    Noutsou M; Georgopoulos A
    J Diabetes Complications; 1999; 13(2):98-104. PubMed ID: 10432174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.